Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats
- Eric Murillo-Rodríguez(corresponding author),
- Reyes Haro,
- Marcela Palomero-Rivero,
- Diana Millán-Aldaco,
- René Drucker-Colín
- Universidad Nacional Autónoma de México,
- Facultad de Medicina
Research Output:
Contribution to journal
Article
Peer-reviewPublication Information
Output type
Research Output:
Contribution to journal
Article
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 353-357 (5 pages)Journal (Volume, Issue Number)
Behavioural Brain Research (Volume 176, Issue 2)Publication milestones
- Published - 25/01/2007
Publication status
Published - 25/01/2007
ISSN
0166-4328Publication IDs
- Scopus: 33845426470
- PubMed: 17098298
Abstract
Modafinil (MOD) is a wakefulness-promoting drug that improves the alertness levels in narcolepsy; however, the molecular mechanism of action remains to be elucidated. We found that after a single icv injection of MOD (10 μg/5 μl) the extracellular levels of dopamine (DA) and l-DOPA collected from the nucleus accumbens were increased and decreased, respectively. Separately, the icv administration of MOD (10 μg/5 μl) to rats enhanced wakefulness (W) whereas diminished sleep during 4 h. Lastly, the alertness induced by MOD was partially antagonized by the sleep-inducing endocannabinoid anandamide (ANA). We conclude that MOD enhances the extracellular levels of DA, promotes W and its effects on sleep are partially blocked by ANA.
Access to documents
Publication metrics
Metrics
SciVal
FWCI
2.65
PlumX, opens in new tab
Mentions
1
83
Captures
60
